SCHEMBL7003889

SCHEMBL7003889

Cc1cc(C2C[C@H]2N)ccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.45
SLC6A2 P23975 3/20 0.45
SLC6A3 Q01959 3/20 0.45
KDM1A O60341 16/20 0.45
KDM1B Q8NB78 3/20 0.44
MAOB P27338 3/20 0.44
MAOA P21397 1/20 0.44
RCOR1 Q9UKL0 2/20 0.44
SLC6A4 P31645 2/20 0.43
CYP2D6 P10635 1/20 0.43
CHRNA1 P02708 1/20 0.43
CHRNG P07510 1/20 0.43
ITGA5 P08648 1/20 0.43
CHRNB1 P11230 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
CHRND Q07001 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003893 1.00 KCNH2 (0.45) KCNH2SLC6A2SLC6A3KDM1AKDM1B
SCHEMBL7092112 1.00 KCNH2 (0.45) KCNH2SLC6A2SLC6A3KDM1AKDM1B
SCHEMBL7001619 0.85 CYP3A4 (0.45) KCNH2SLC6A2SLC6A3KDM1AKDM1B
SCHEMBL7089683 0.85 CYP3A4 (0.45) KCNH2SLC6A2SLC6A3KDM1AKDM1B
SCHEMBL7001620 0.85 CYP3A4 (0.45) KCNH2SLC6A2SLC6A3KDM1AKDM1B
SCHEMBL8134479 0.85 CYP3A4 (0.45) KCNH2SLC6A2SLC6A3KDM1AKDM1B
SCHEMBL6997479 0.82 HTR2A (0.59) KCNH2KDM1AKDM1BMAOBMAOA
SCHEMBL12971950 0.82 HTR2A (0.59) KCNH2KDM1AKDM1BMAOBMAOA
SCHEMBL6997477 0.82 HTR2A (0.59) KCNH2KDM1AKDM1BMAOBMAOA
SCHEMBL7004269 0.82 KDM1A (0.48) KCNH2SLC6A2SLC6A3KDM1AKDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed